题名 | BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small-Cell Lung Cancer |
链接 | http://jco.ascopubs.org/content/33/19/2197.long |
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |